T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines

Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey Barnes, Stefan K. Barta, Michael Choi, Mark W. Clemens, Ahmet Dogan, John P. Greer, Ahmad Halwani, M. Haverkos Bradley, Richard T. Hoppe, Eric Jacobsen, Deepa Jagadeesh, Youn H. Kim, Matthew A. Lunning, Amitkumar Mehta, Neha Mehta-Shah, Yahurio Oki, Elise A. OlsenBarbara Pro, Saurabh A. Rajguru, Satish Shanbhag, Andrei Shustov, Lubomir Sokol, Pallawi Torka, Ryan Wilcox, Basem William, Jasmine Zain, Mary A. Dwyer, Hema Sundar

Research output: Contribution to journalReview article

16 Scopus citations

Abstract

Natural killer (NK)/T-cell lymphomas are a rare and distinct subtype of non-Hodgkin's lymphomas. NK/T-cell lymphomas are predominantly extranodal and most of these are nasal type, often localized to the upper aerodigestive tract. Because extranodal NK/T-cell lymphomas (ENKL) are rare malignancies, randomized trials comparing different regimens have not been conducted to date and standard therapy has not yet been established for these patients. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with ENKL as outlined in the NCCN Guidelines for T-Cell Lymphomas.

Original languageEnglish (US)
Pages (from-to)123-135
Number of pages13
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume16
Issue number2
DOIs
StatePublished - Feb 1 2018

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines'. Together they form a unique fingerprint.

  • Cite this

    Horwitz, S. M., Ansell, S. M., Ai, W. Z., Barnes, J., Barta, S. K., Choi, M., Clemens, M. W., Dogan, A., Greer, J. P., Halwani, A., Bradley, M. H., Hoppe, R. T., Jacobsen, E., Jagadeesh, D., Kim, Y. H., Lunning, M. A., Mehta, A., Mehta-Shah, N., Oki, Y., ... Sundar, H. (2018). T-Cell Lymphomas, Version 2.2018 Featured Updates to the NCCN Guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(2), 123-135. https://doi.org/10.6004/jnccn.2018.0007